175 related articles for article (PubMed ID: 38811761)
1. Trans-nuclease activity of Cas9 activated by DNA or RNA target binding.
Chen J; Chen Y; Huang L; Lin X; Chen H; Xiang W; Liu L
Nat Biotechnol; 2024 May; ():. PubMed ID: 38811761
[TBL] [Abstract][Full Text] [Related]
2. Naked-eye detection of site-specific ssRNA and ssDNA using PAMmer-assisted CRISPR/Cas9 coupling with exponential amplification reaction.
Wang X; Chen X; Chu C; Deng Y; Yang M; Huo D; Xu F; Hou C; Lv J
Talanta; 2021 Oct; 233():122554. PubMed ID: 34215057
[TBL] [Abstract][Full Text] [Related]
3. The CRISPR-associated DNA-cleaving enzyme Cpf1 also processes precursor CRISPR RNA.
Fonfara I; Richter H; Bratovič M; Le Rhun A; Charpentier E
Nature; 2016 Apr; 532(7600):517-21. PubMed ID: 27096362
[TBL] [Abstract][Full Text] [Related]
4. trans Single-Stranded DNA Cleavage via CRISPR/Cas14a1 Activated by Target RNA without Destruction.
Wei Y; Yang Z; Zong C; Wang B; Ge X; Tan X; Liu X; Tao Z; Wang P; Ma C; Wan Y; Li J
Angew Chem Int Ed Engl; 2021 Nov; 60(45):24241-24247. PubMed ID: 34553468
[TBL] [Abstract][Full Text] [Related]
5. Identification of RNA Binding Partners of CRISPR-Cas Proteins in Prokaryotes Using RIP-Seq.
Sharma S; Sharma CM
Methods Mol Biol; 2022; 2404():111-133. PubMed ID: 34694606
[TBL] [Abstract][Full Text] [Related]
6. Coordinated Actions of Cas9 HNH and RuvC Nuclease Domains Are Regulated by the Bridge Helix and the Target DNA Sequence.
Babu K; Kathiresan V; Kumari P; Newsom S; Parameshwaran HP; Chen X; Liu J; Qin PZ; Rajan R
Biochemistry; 2021 Dec; 60(49):3783-3800. PubMed ID: 34757726
[TBL] [Abstract][Full Text] [Related]
7. A new family of CRISPR-type V nucleases with C-rich PAM recognition.
Urbaitis T; Gasiunas G; Young JK; Hou Z; Paulraj S; Godliauskaite E; Juskeviciene MM; Stitilyte M; Jasnauskaite M; Mabuchi M; Robb GB; Siksnys V
EMBO Rep; 2022 Dec; 23(12):e55481. PubMed ID: 36268581
[TBL] [Abstract][Full Text] [Related]
8. DNA targeting by subtype I-D CRISPR-Cas shows type I and type III features.
Lin J; Fuglsang A; Kjeldsen AL; Sun K; Bhoobalan-Chitty Y; Peng X
Nucleic Acids Res; 2020 Oct; 48(18):10470-10478. PubMed ID: 32960267
[TBL] [Abstract][Full Text] [Related]
9. Programmable RNA recognition and cleavage by CRISPR/Cas9.
O'Connell MR; Oakes BL; Sternberg SH; East-Seletsky A; Kaplan M; Doudna JA
Nature; 2014 Dec; 516(7530):263-6. PubMed ID: 25274302
[TBL] [Abstract][Full Text] [Related]
10. Single-Stranded DNA Cleavage by Divergent CRISPR-Cas9 Enzymes.
Ma E; Harrington LB; O'Connell MR; Zhou K; Doudna JA
Mol Cell; 2015 Nov; 60(3):398-407. PubMed ID: 26545076
[TBL] [Abstract][Full Text] [Related]
11. CRISPR-Cas12a target binding unleashes indiscriminate single-stranded DNase activity.
Chen JS; Ma E; Harrington LB; Da Costa M; Tian X; Palefsky JM; Doudna JA
Science; 2018 Apr; 360(6387):436-439. PubMed ID: 29449511
[TBL] [Abstract][Full Text] [Related]
12. DNA Unwinding Is the Primary Determinant of CRISPR-Cas9 Activity.
Gong S; Yu HH; Johnson KA; Taylor DW
Cell Rep; 2018 Jan; 22(2):359-371. PubMed ID: 29320733
[TBL] [Abstract][Full Text] [Related]
13. RNA-dependent RNA targeting by CRISPR-Cas9.
Strutt SC; Torrez RM; Kaya E; Negrete OA; Doudna JA
Elife; 2018 Jan; 7():. PubMed ID: 29303478
[TBL] [Abstract][Full Text] [Related]
14. A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity.
Jinek M; Chylinski K; Fonfara I; Hauer M; Doudna JA; Charpentier E
Science; 2012 Aug; 337(6096):816-21. PubMed ID: 22745249
[TBL] [Abstract][Full Text] [Related]
15. The tracrRNA and Cas9 families of type II CRISPR-Cas immunity systems.
Chylinski K; Le Rhun A; Charpentier E
RNA Biol; 2013 May; 10(5):726-37. PubMed ID: 23563642
[TBL] [Abstract][Full Text] [Related]
16. Probing the structural dynamics of the CRISPR-Cas9 RNA-guided DNA-cleavage system by coarse-grained modeling.
Zheng W
Proteins; 2017 Feb; 85(2):342-353. PubMed ID: 27936513
[TBL] [Abstract][Full Text] [Related]
17. Prediction and Validation of Native and Engineered Cas9 Guide Sequences.
Briner AE; Henriksen ED; Barrangou R
Cold Spring Harb Protoc; 2016 Jul; 2016(7):. PubMed ID: 27371591
[TBL] [Abstract][Full Text] [Related]
18. Structural basis for RNA-guided DNA cleavage by IscB-ωRNA and mechanistic comparison with Cas9.
Schuler G; Hu C; Ke A
Science; 2022 Jun; 376(6600):1476-1481. PubMed ID: 35617371
[TBL] [Abstract][Full Text] [Related]
19. CRISPR-Cas9 Structures and Mechanisms.
Jiang F; Doudna JA
Annu Rev Biophys; 2017 May; 46():505-529. PubMed ID: 28375731
[TBL] [Abstract][Full Text] [Related]
20. Kinetic characterization of Cas9 enzymes.
Liu MS; Gong S; Yu HH; Taylor DW; Johnson KA
Methods Enzymol; 2019; 616():289-311. PubMed ID: 30691648
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
